| Literature DB >> 32626733 |
Li-Peng Guo1, Si-Xu Liu2, Qin Yang2, Hong-Yang Liu3, Lu-Lu Xu4, Yu-Hua Hao4, Xiao-Qing Zhang4.
Abstract
Acute kidney injury (AKI) is a common complication of sepsis and has also been observed in some patients suffering from the new coronavirus pneumonia COVID-19, which is currently a major global concern. Thymoquinone (TQ) is one of the most active ingredients in Nigella sativa seeds. It has a variety of beneficial properties including anti-inflammatory and antioxidative activities. Here, we investigated the possible protective effects of TQ against kidney damage in septic BALB/c mice. Eight-week-old male BALB/c mice were divided into four groups: control, TQ, cecal ligation and puncture (CLP), and TQ+CLP. CLP was performed after 2 weeks of TQ gavage. After 48 h, we measured the histopathological alterations in the kidney tissue and the serum levels of creatinine (CRE) and blood urea nitrogen (BUN). We also evaluated pyroptosis (NLRP3, caspase-1), apoptosis (caspase-3, caspase-8), proinflammatory (TNF-α, IL-1β, and IL-6)-related protein and gene expression levels. Our results demonstrated that TQ inhibited CLP-induced increased serum CRE and BUN levels. It also significantly inhibited the high levels of NLRP3, caspase-1, caspase-3, caspase-8, TNF-α, IL-1β, and IL-6 induced by CLP. Furthermore, NF-κB protein level was significantly decreased in the TQ+CLP group than in the CLP group. Together, our results indicate that TQ may be a potential therapeutic agent for sepsis-induced AKI.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32626733 PMCID: PMC7315249 DOI: 10.1155/2020/1594726
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Metabolic characteristic results.
| Control | TQ | CLP | TQ+CLP | |
|---|---|---|---|---|
| Body weight (g) | 24.12 ± 1.63 | 25.33 ± 1.06 | 23.23 ± 0.81 | 24.63 ± 1.21 |
| Kidney/body weight (mg/g) | 6.82 ± 1.35 | 6.23 ± 0.57 | 6.11 ± 0.22 | 6.13 ± 0.69 |
| BUN (mg/dl) | 22.37 ± 1.96∗∗ | 25.42 ± 2.43∗∗ | 107.62 ± 5.61 | 66.19 ± 4.36∗ |
| CRE (mmol/ml) | 49.24 ± 7.83∗ | 53.21 ± 6.91∗ | 156.87 ± 11.57 | 63.28 ± 7.87∗ |
Data are means ± SEM; n = 8 per group. ∗P < 0.05 vs. the CLP group; ∗∗P < 0.01 vs. the CLP group.
Figure 1Inflammatory cell infiltration in kidney tissues from the BALB/c mice of the four groups with different treatments. The arrows indicated damage. Magnification 40x.
Figure 2Relative mRNA expression levels of IL-1β, IL-6, and TNF-α expression in the kidney tissue of the four groups after different treatments. Data are means ± SEM; n = 6 per group. ∗P < 0.05 vs. the CLP group; ∗∗P < 0.01 vs. the CLP group.
Figure 3(a) Representative immunohistochemistry staining for NLRP3 and caspase-1 in kidney tissue of mice with different treatments. Magnification 40x. Arrows indicate positively stained cells (n = 3). (b) Immunoblotting for NLRP3 and caspase-1 in kidney tissue. (c) Bar graph showing quantification of NLRP and caspase-1protein expression. Data are means ± SEM; n = 3 per group. ∗P < 0.05 vs. the CLP group.
Figure 4(a) Immunoblotting for caspase-3 and caspase-8 in kidney tissue. (b) Bar graph showing quantification of caspase-3 and caspase-8 protein expression. Data are means ± SEM; n = 3 per group. ∗P < 0.05 vs. the CLP group.
Figure 5NF-κB protein expression in the kidney tissue of the four groups after different treatments. (a) Immunoblotting analysis to detect the NF-κB expression in the kidney tissues. (b) Bar graph depicting the semiquantification of the NF-κB expression. TQ suppressed the expression of the NF-κB protein in the CLP group mice. Data are means ± SEM; n = 3 per group. ∗P < 0.05 vs. the CLP group.